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ABSTRACT
Accurate estimation of cancer mortality rates and the comparison across cancer sites, popula-
tions or time periods is crucial to public health, as identification of vulnerable groups who suffer
the most from these diseases may lead to efficient cancer care and control with timely treatment.
Because cancer mortality rate varies with age, comparisons require age–standardization using a
reference population. The current method of using the Year 2000 Population Standard is standard
practice, but serious concerns have been raised about its lack of justification. We have found that
using the US Year 2000 Population Standard as reference overestimates prostate cancer mortality
rates by 12–91% during the period 1970–2009 across all six sampled U.S. states, and also underesti-
mates case fatality rates by 9–78% across six cancer sites, including female breast, cervix, prostate,
lung, leukemia and colon-rectum. We develop a mean reference population method to minimize the
bias using mathematical optimization theory and statistical modeling. The method corrects the bias
to the largest extent in terms of squared loss and can be applied broadly to studies of many diseases.
Keywords: Age-standardization; Bias; Crude rate; Optimization
Introduction
Cancer is one of the leading causes of death in the United States and a major public health
concern [1-5]. Cancer mortality rates are often reported in age-specific groups, making it difficult
to extrapolate the overall mortality assessment or generate comparisons across populations [6].
Researchers often calculate a summary rate, such as the crude rate, which is an average of the age-
specific mortality rates weighted to the proportions of age groups in the population. Such summary
rates depend on the age-specific mortality rates and the population’s age structure, where the latter
may vary largely and cause unfair comparison among populations, presenting numerical illusion of
large differences in the summary rate even as the age-specific mortality rates remain the same
[7]. This discrepancy motivated the direct age-standardization procedure for comparing mortality
rates across populations [7-9] using a standard population as reference, such as the US Year 2000
Population Standard in current practice.
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The age-standardization method calculates an age-adjusted rate using the age structure of a
standard population to compare disease rates across populations or time periods. This method has
been extensively adopted by the United States and world health agencies [4-5,10-12] following a
memorandum from the Secretary of the U.S. Department of Health and Human Services in 1998 [13]
mandating the use of the US Year 2000 Population Standard to calculate age-adjusted mortality
rate starting 1999 for more consistent reporting of mortality rate [14]. Accordingly, the US Year
2000 Population Standard or the Year 2000 World Standard Population has been used as reference
in public health reports by many U.S. states [15-20] and worldwide agencies [12].
Although age-standardization provides a way to compare disease rate among populations and
has acknowledged merits [6-7,10-12], the current approach of using standard reference population
also has caveats. It has been noted that choosing different reference populations may change the
age-adjusted mortality rates dramatically and may also alter the ranking [7, 21]. As a result, the
selection of standard population is still in debate [7, 12]. On one hand, selecting the Year 2000
Population Standard keeps the mortality rate adjustment consistent with a contemporary reference
population [13, 14], making the comparison procedure easy to follow with uniformity [21]. On the
other hand, a study by the World Health Organization (WHO) pointed out “There is clearly no
conceptual justification for choosing one standard over another, hence the choice is arbitrary” [12].
Further, a health disparities study attributed declining racial/ethnic and socioeconomic inequalities
in health to the change of the reference population from Year 1940, 1970 to Year 2000, a “statistical
illusion” due to the use of the Year 2000 Population Standard [23]. This illusive effect of the Y2K or
millennium bug is not the result of a technical problem as in the computer programming case, but
rather of a more difficult methodological one that requires theoretical research in quantitative sci-
ence. The change of reference from US Year 1940 Population to US Year 2000 Population Standard
may cause age-adjusted mortality rate to increase largely [14], sometimes even more than doubling
in size [24]. The fact that the conclusion of mortality rate comparison depends on the choice of
reference population creates confusions and misinterpretation [23]. Consequently, concerns about
inadequate public health policymaking on healthcare, racial/ethnic and socioeconomic inequalities
that result from improper comparisons need to be addressed urgently.
In this study, we investigated the issue of reference population selection using the Surveillance,
Epidemiology and End Results (SEER) database [25]. We analyzed prostate cancer mortality rates
in six U.S. states (California, Massachusetts, Michigan, Missouri, New Jersey and New York) from
1970 to 2009 and also examined the U.S. case fatality rates in 2008 of six sites: female breast, cervix,
prostate, lung, leukemia, and colon-rectum. We found that the age-standardization procedure using
the US Year 2000 Population Standard as reference overestimated prostate cancer mortality rates
in all six states and underestimated case fatality rates of all six cancer sites. This finding clearly
indicates that bias has been introduced by the age-standardization procedure. To minimize the bias,
we developed a mean reference population method to compare different populations. This method
possesses a number of advantageous properties. First, the mean reference population minimizes
the overall squared bias among all convex linear combinations. Second, by construction the mean
reference population resembles the age profiles of all populations in comparison and thus represents
them accurately while a standard population may present a largely different profile. Third, the
existence and uniqueness of such a mean reference population is guaranteed by the mathematical
optimization theory and can be computed using a mathematical quadratic programming method
or a statistical sampling method. Fourth, the mean reference population method does not depend
on the specifics of cancer mortality and can thus be applied to studies of incidence and mortality
rates of other diseases. We show that the mean reference population method reduced to a large
extent the overall bias associated with the use of the US Year 2000 Population Standard in the
age-standardization procedure and yielded cancer mortality rate close to the crude rate.
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Figure 1: Comparison of age-adjusted mortality rates using the US Year 2000 Population Standard
and the mean reference population to the crude rate of prostate cancer in the state of California
during 1970-2009.
Results
By definition, the crude rate calculated with the total probability rule provides an unbiased estimate
of the mortality rate [26]. To achieve fair comparison, however, a reference population is needed
to remove artifacts due to varying age structure and bias is inevitably introduced by a reference
population. See Material and Methods for more details and the definitions of various rates.
Compared to the crude rate, the age-adjusted rate using the US Year 2000 Population Standard
as reference overestimated prostate cancer mortality rate by 12% to 91% in all eight periods studied
during 1970–2009, consistently in all six states (Tables 1). The cumulative rate, which takes the sum
of the age-specific mortality rates from age 40 to 79 of each population [6], yielded relative deviation
of 1227% to 3145%, or 13 to 32 times that of the crude rate. In contrast, the mean reference
population yielded age-adjusted rates much closer to the crude rates, with relative deviation between
-25% and 27% and no systematic deviation towards either overestimation or underestimation. Fig.
1 illustrates the comparison in the State of California. Similar patterns were observed in the other
five states (Fig. S1 in Supplementary Material). Due to its large scale, the cumulative rate is not
shown.
Table 2 compares the observed number of deaths with the expected one in each population
by the crude rate, the age-adjusted rates using the US Year 2000 Population Standard and using
the mean reference population. The crude rate yielded exactly the same number of deaths as the
observed, indicating unbiased estimation, whereas the age-adjusted rate using the US Year 2000
Population Standard yielded much larger number of deaths than the observed, indicating biased
estimation by age-adjusted rate. Overall, the mean reference population yielded a more accurate
estimation of the number of deaths than the US Year 2000 Population Standard. The expected
number of deaths by the cumulative rate was not calculated because the cumulative rate is not a
weighted average of the age-specific rates and thus is not a rate in a strict sense.
The age-adjusted rate using the US Year 2000 Population Standard as reference underestimated
3
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Figure 2: Comparison of age-adjusted case fatality rates using the reference of US Year 2000
Population Standard and the mean reference population to the unbiased crude rate of six cancer
sites in 2008 in the United States.
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Figure 3: Comparison of age profile of the reference populations and the cancer patient popula-
tions of six sites. The profile of the mean reference population was similar to those of all cancer
patient populations except for leukemia (which differed from others in early ages). In contrast,
the decreasing trend of the US Year 2000 Population Standard differed largely from the increasing
trend of the others, resulting in large bias in age-adjusted rate.
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the case fatality rate of all six cancer sites, as shown in Table 3. The relative deviations were -78%,
-52%, -42%, -39%, -32% and -9% for cancer of prostate, lung, cervix, leukemia, female breast,
and colon–rectum, respectively, indicating underestimation consistently across cancer sites. This
discrepancy altered the ranking between leukemia and colon-rectum cancer. The cumulative rate
overestimated the case fatality rate by 284–755%. In contrast, the mean reference population
yielded estimate much closer to the crude rate, with a mean deviation equal to 403.4, 90% less than
that by the US Year 2000 Population Standard (4305.1) and 99% less than that by the cumulative
rate (53351.3). Fig. 2 illustrates the comparison, again with the cumulative rate not shown because
of its large scale.
We then explored possible explanations for the large contrast of the age-adjusted rates between
the two references of the US Year 2000 Population Standard and the mean reference population.
We first examined the age profile of the reference populations using the case fatality study data and
compared them to those of the six cancer patient populations. As shown in Fig. 3, five out of six
cancers (except for leukemia) had virtually no patients before age 20, followed by a sharp increase
between age 20, a peak between age 50 and 70 and a decline thereafter (except for colon-rectum
cancer, which increased through age 85+). Mortality rates for leukemia were positive in early age,
decreased slowly between age 15 and 40, and then increased thereafter. Overall, the mean reference
population had an increasing trend similar to those of the six cancers, suggesting that it represented
the cancer patient populations accurately. In contrast, the US Year 2000 Population Standard had
an overall decreasing trend, staying large before age 20, peaking around 40 and then decreasing
sharply thereafter. This sharp contrast suggests that the US Year 2000 Population Standard did
not represent cancer patient populations, which explains why it yielded large deviation from the
crude rate in comparing case fatality rates.
We then examined the weights of the reference populations. The mean reference population
had a positive weight for each cancer site by construction and accurately represented the six cancer
patient populations on the average.
nmean = 0.5756n1 + 0.2172n2 + 0.0261n3 + 0.1757n4 + 0.0105n5 + 0.0048n6 ,
where n1, . . . ,n6 are the population proportions of female breast, cervix, prostate, lung, leukemia,
and colon-rectum, respectively. We further decomposed the US Year 2000 Population Standard by
the six cancer patient populations using a linear regression model with no intercept for comparison
with the above nmean.
nUS2000 = −1.1476n1 + 0.6034n2 + 0.3183n3 − 0.4891n4 + 1.6838n5 − 0.0017n6 .
The regression yielded three negative weights on breast, lung and colon-rectum cancers. In addition,
the sum of the absolute values of all weights was 4.24, much greater than 1 as in the mean reference
population. This result suggests that the US Year 2000 Population Standard was not “close” to a
weighted average of the six cancer patient populations and thus was not a representative of them.
We also examined the population profile of the six states during the period 1970-2009 (Fig.
S2-S7). Although the population in each state remained relatively stable, the effect of aging was
observed by a shift of the peak from 1970 to 2009, indicating the change of population structure,
the needs of age-standardization and the subsequent minimization of the overall bias as shown in
Table 1 and Fig. 1 and S1.
Discussion
Accurate estimation of cancer mortality rate is a challenging task and has a major impact on
cancer care and public health policymaking for cancer prevention, treatment and control [27-28].
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The method of direct age-standardization has been studied for over a century [8]. Although concerns
about the arbitrary selection of reference population are not new, they have become more urgent
in recent years with the U.S. and world health agencies changing the reference population to
reflect the contemporary, aging population structure. Such a change, though appealing in keeping
mortality rate estimation consistent with a contemporary reference population, still lacks theoretical
justification. As mentioned previously, the observed illusive effect on the declining racial/ethnic
and socioeconomic inequalities raises more questions and demands renewed comparison in various
aspects of disease incidence and mortality rates. The confusion caused by the selection of reference
population is far from being clarified, and though a mandate of using a standard population as
reference may help to streamline the age-standardization task, it may not help to adequately address
the above concerns. Further theoretical research is urgently needed, more so than ever before.
We have demonstrated that age-standardization using the US Year 2000 Population Standard
overestimated prostate cancer mortality rate by up to 91% and underestimated case fatality rate by
up to 78%. Such large bias may result in confusion and misinterpretation of cancer mortality. For
example, prostate cancer mortality may be misinterpreted as much higher than it actually was in all
six states, and lung cancer case fatality rate may be misinterpreted as less than 10,000 per 100,000
person-year, while the actual rate was more than doubled (> 19, 700 per 100,000 person-year). Our
observation is consistent with the concerns raised in the literature [7, 21, 22].
Since the age-adjusted rate using the US Year 2000 Population Standard has been widely used in
epidemiological studies and public heath reports, it has been regarded as the standard approach to
comparing disease rates across populations. Many public health reports use it to generate disease
rate estimation while acknowledging that the crude rate yields poor comparison with potential
bias. For the first time, our study points out that the crude rate is unbiased and age-adjusted
rates are biased. The use of a standard population in the direct age-standardization introduces
bias and results in confusion and misinterpretation, as shown in Tables 1 and 2. The merit of
the age-standardization is that it provides an equal footing for comparing disease rates among
populations with different age structure, eliminating artifacts introduced by different population
structure. Furthermore, we show in this paper that as long as one uses a common age structure
to calculate age-adjusted rates, such equal footing is guaranteed. However, equal footing does not
necessarily yield fair comparison because an age-structure may be in favor of one population over
others. Hence, an equal footing age-structure may not be used as the only criterion for the fairness
of comparison. This issue motivated us to search for a population that minimized the overall bias
among all possible reference populations and led us to construct the mean reference population
based on the populations in comparison. Our mean reference population method not only provided
a common population structure for comparison but also minimized the overall bias.
Although the effect of age-standardization differed in the two cancer mortality studies, over-
estimation of mortality rate and underestimation of case fatality rate, both showed a consistent
lack of calibration by age-adjusted rate, indicating the need for improvement. Our mean reference
population method minimizes the overall bias, and may also help to address the issue of arbitrary
selection of reference population raised in the WHO report [12].
Although cancer case fatality rates may be inaccurate due to lead bias in cancer diagnosis, the
principle of our analysis remains the same, and the underestimation of case fatality rates by the
US Year 2000 Population Standard remains a valid conclusion. For example, take prostate cancer,
a disease with a late onset at age 35 or older (Table S1). A major proportion (45%) of the US Year
2000 Population Standard is younger than age 35, a population in which prostate cancer rarely
develops (assuming equal distribution by age between males and females, thus gender effect need
not be considered). Hence, the age-standardization by the US Year 2000 Population Standard only
accounts for 55% weight on death from prostate cancer, largely underestimating the case fatality
6
rate. Similar explanation holds for other cancers.
We appreciate that although the mean reference population provides a unique reference pop-
ulation and minimizes the overall bias of age-adjusted rate among given populations, it does not
remain the same in different studies and has to be constructed for each comparison study. This
leads to technical inconvenience in comparing disease rates. To resolve this issue, we plan to pro-
vide a computer software package to implement the procedure, for which computation of optimal
weights and storage of population proportions of racial and sex groups in geographic locations is
inexpensive.
We conclude that direct age-standardization using a standard population may lead to inaccurate
estimation and incorrect interpretation, resulting in confusions and inappropriate decision and
policy making. It is hoped that the mean reference population method may lead to improved
cancer patient care and efficient healthcare management. Furthermore, since the method relies
on no specification of cancer mortality rates, it applies broadly to studies comparing incidence or
mortality rates of a wide range of diseases in varied countries and geographic regions.
Materials and Methods
Data
Prostate cancer mortality rates and population proportions of five year age groups and five year
periods during the years 1970 - 2009 were generated for six US states (California, Massachusetts,
Michigan, Missouri, New Jersey, and New York), from the Surveillance, Epidemiology and End
Results (SEER) database [25] using the SEER*Stat software version 8.0.4 [29]. These six states
were selected because they used the age–standardization method to generate state public health
reports of cancer mortality [15-20]. The SEER database consists of cancer incidence and mortality
data of U.S. cancer registries in a growing number (nine and more) of metropolitan areas since the
1970s. Hence research results based on the SEER database are often interpreted as the results for
the United States.
The U.S. case fatality rates in 2008 were generated using the SEER database and the Cancer
Prevalence database of the NCI/NIH [30]. We first generated the U.S. cancer mortality rates
for each cancer site with the SEER*Stat software, and then calculated the case fatality rates
using the prevalence of each cancer site estimated by the software CanQues Version 4.2 [30]. See
Supplementary Material for details.
Methods
Age-standardization for comparing mortality rate across populations Cancer mortality
rate varies with age (Tables S3, S5, S7, S9, S11 and S13), and a summary rate (e.g. the crude
rate) is often preferred to a sequence of age-specific rates in comparing the mortality [6-7,10-12].
The age-standardization yields an age-adjusted rate, a weighted average of the age-specific rates
ma with selected weights na,
radj =
A∑
a=1
mana . (1)
Age-adjusted rates Four rates were calculated to summarize the age-specific mortality rates
for comparison, the crude rate, the cumulative rate, age-adjusted rates using the US Year 2000
Population Standard and using the mean reference population. They were calculated as follows for
given age-specific mortality rate mia, population proportion nia of population i, and population
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proportion of a standard population n0a. The crude rate rcrude i of prostate cancer mortality
in population i in each state and each period during 1970–2009 was calculated using the total
probability rule [26]
rcrude i =
A∑
a=1
miania,
where the weights were its own population proportions nia. The US crude case fatality rate of each
cancer site in 2008 was calculated similarly. The cumulative rate rcumul i of each population i was
calculated to be the sum of the age–specific mortality rates from age 40-44 to age 75-79 for each
state and each period [6], rcumul i =
∑75
a=40mia, where the weights nia = 1 for a = 40, 45, . . . , 75,
and 0 otherwise. Each age-adjusted rate was calculated following the direct age-standardization
procedure in equation (1) see [6]. The US 2000 age-adjusted rate rUS2000 was calculated using the
US Year 2000 Population Standard proportions nUS2000 a as weights, and the mean reference rate
rmean was calculated using a mean reference population proportion nmean a as weights, where the
mean reference population was constructed using a convex linear combination of the proportions
nia of the populations in comparison. See Statistical Modeling below for details.
Unbiased estimation of overall mortality by crude rate Assume we have A age groups.
The A age-specific mortality rates of each population form an A-vector m = (m1, . . . ,mA)
T . Also
assume the proportion of a given population with the disease is n = (n1, . . . , nA)
T for A age groups,∑A
a=1 na = 1. Assume that a study has p populations, and each population has a mortality rate
vector mi and a corresponding population proportion vector ni, i = 1, . . . , p. The mortality rate
of each population in a given period of time is defined in [6] as
r =
Total number of deaths during given period
Mid point population × duration of period
.
By the total probability rule [26], the crude mortality rate of each population is estimated with
rˆ =
∑A
a=1mana = m
T
n, an inner product of the two vectors m and n, i.e. the crude mortality
rate is a weighted average of the age-specific rates. It is shown below that the crude mortality rate
provides an unbiased estimate of the overall mortality rate over one year period for each population.
This explains why the crude rate yielded the same number of deaths as the observed (Table 2).
rˆ =
A∑
a=1
mana =
A∑
a=1
Number of deaths in a−th age group
Population in a−th age group× 1 year
×
Population in a−th age group
Total population
=
A∑
a=1
Number of deaths in a−th age group
Total population × 1 year
=
Total number of deaths
Total population × 1 year
. (2)
Thus the unbiased estimates of the mortality rates of the p populations are
rˆ1 =m
T
1 n1 , · · · , rˆp =m
T
p np . (3)
Comparing multiple populations with age-adjusted mortality rates Equation (3) provides
an unbiased estimate of the overall mortality rate for each population. However, the rates so
generated cannot provide a fair comparison across populations as different populations may have
different age structures. With a late-onset disease, it is very likely that an older population yields
a higher mortality rate than a younger population, even if the two populations have the same
age-specific mortality rates [7, 10]. For fairer comparison, a direct age-standardization procedure
was studied [7], in which an age-adjusted rate was calculated based on age-specific rates m of
a population in comparison and age structure n of a standard population, such as the US Year
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2000 Population Standard [4,5,10] or the WHO World Standard Population [12]. The age-adjusted
mortality rate was calculated as Ri =m
T
i n for the i-th population. The expected number of deaths
was thus calculated by multiplying the rate Ri by the total population Ni of population i, RiNi.
The calculation of expected number of deaths allowed comparison of the rate among populations,
and more importantly allowed comparison of the expected number of deaths of each population to
the observed, assessing the bias of each rate.
Bias introduced by age-standardization We made four observations below.
1) The crude rate in equation (3) provides unbiased estimation for each population. 2) An age-
adjusted rate using a reference population n may deviate from the crude rate and introduce bias.
The deviation is calculated with bi =m
T
i n−m
T
i ni =m
T
i (n−ni). 3) The bias is often inevitable
in comparison among multiple populations. bi 6= 0 unless the difference vector n−ni between the
reference population and the i-th population is perpendicular to the rate vector mi. Since multiple
populations are often compared in a given study, the chance that one single reference population
n makes the deviation of all populations equal to 0 is extremely small because n = (n1, . . . , nA)
T
needs to satisfy conditions na ≥ 0 and
∑A
a=1 na = 1. 4) It is thus desirable to find a reference
population n to minimize the overall bias for all p populations [7].
The difference between age-adjusted and crude rates represents an estimate of bias caused by
using a reference population. We define a relative deviation to be the deviation of an age-adjusted
rate (Radjust) as a percentage of the crude rate (Rcrude),
Reletive Deviation =
Radjust −Rcrude
Rcrude
× 100%.
A positive value indicates overestimation and a negative one indicates underestimation.
To calibrate the age-adjusted rate with a mean reference population, we took a weighted average
of the proportions of all populations in comparison, i.e. the proportions of six US cancer patient
populations (Table S1) or the population proportions in eight periods of each state (Tables S4, S6,
S8, S10, S12 and S14). We selected the weights by minimizing the total deviation, which is defined
as the sum of squares of the deviations across all populations in comparison. By definition, the
mean reference population is optimal in calibrating the age-adjusted mortality rate.
We compared the age-adjusted rate with the crude rate, using the US Year 2000 Population
Standard or the mean reference population as reference. We used the mean deviation (averaged
over all populations in comparison) to assess each age-adjusted rate. See equation (8) below for
the definition of mean deviation. We also compared age profile of the US Year 2000 Population
Standard and the mean reference population with the populations in comparison, as shown in Fig.
3.
Criteria in searching for a reference population We searched for a reference population n
by minimizing the total squared deviation of p populations
min
n
{
p∑
i=1
b2i ≡
p∑
i=1
[mTi (n− ni)]
2
}
. (4)
Technically, a reference population n needs to satisfy na ≥ 0 and
∑A
a=1 na = 1 for population
proportion. However, these conditions may not be enough to ensure that the reference population
is “close” to or representative of the given populations n1, . . . ,np. In order to make the reference
population represent the given populations, we further required that the search for the reference
population be conducted among weighted averages of the given populations. Mathematically they
are convex linear combinations of these populations n = t1n1+. . .+tpnp with ti ≥ 0 for i = 1, . . . , p
and
∑p
i=1 ti = 1. Such a convex linear combination ensured that the target reference population n
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was representative and retained the characteristics of the p populations. Therefore, our objective
was to search for a set of weights ti ≥ 0 for i = 1, . . . , p satisfying
∑p
i=1 ti = 1 such that the
linear combination n minimized the total deviation in equation (4). This approach formulated the
objective into a mathematical optimization problem [32, 33].
Optimization by quadratic programming Let f(t) =
∑p
i=1 b
2
i be the total deviation to be
minimized. Then
f(t) =
p∑
i=1
(mTi n− ri)
2 = ‖MTn−R‖2 , (5)
where M = (m1, . . . ,mp) is an A × p matrix. The column vectors R = (r1, r2, . . . , rp)
T and
t = (t1, . . . , tp)
T . ‖ · ‖ is the Euclidean norm. Since n = t1n1 + . . . + tpnp, f(t) is a quadratic
function of t1, . . . , tp, and can be minimized in a compact domain. Since the constraints ti ≥ 0 for
i = 1, . . . , p and
∑p
i=1 ti = 1 form a simplex D in a p-dimensional space, which is compact, the
function f(t) can be minimized in D as stated in the following theorem.
Theorem 1. The quadratic function f(t) in equation (5) has a minimum in the domain D, which
can be attained at some finite point t0 ∈ D.
Theorem 1 can be proved based on the continuity of function f(t) in the compact domain D.
This minimization problem is equivalent to a quadratic programming problem using the following
Lagrange multiplier for convex programming ([32], page 13), for which the existence of the solution
is guaranteed by the Khun-Tucker Theorem.
min
(t,λ, µ)
[f(t)− (λ1t1 + . . .+ λptp) + µ{(t1 + . . .+ tp)− 1}] , (6)
where λ = (λ1, . . . , λp)
T with λ1, . . . , λp ≥ 0 and µ is a real number. We also provide the uniqueness
of the solution.
Theorem 2. The quadratic function f(t) in equation (5) has a unique minimum in the domain D.
We prove Theorem 2 by contradiction. Assuming that there exist two distinct minima t1 6=
t2 (including local minimum) and further f(t1) ≤ f(t2) without loss of generality, by Jensen’s
inequality [33] one has f(st1 + (1 − s)t2) ≤ sf(t1) + (1 − s)f(t2) ≤ f(t2) for any real number
0 ≤ s ≤ 1 with convex function f(t), which implies that t2 is not a local or global minimum, unless
f(t1) = f(st1+(1− s)t2) = f(t2), which is impossible for a quadratic function. This contradiction
completes the proof.
Algorithm for computing the optimal weights and reference population To solve the
optimization problem, the following two approaches can be employed.
I. Quadratic programming approach The optimization problem in equation (6) leads to an
equation system (7) below using the Lagrange multiplier approach by minimizing the objective
function, see [32] for details.
g(t,λ, µ) = f(t)− tTλ+ µtT1
= (MTNt−R)T (MTNt−R)− tTλ+ µ(tT1− 1)
with parameters t,λ and µ, where N = (n1, . . . ,np) is a matrix with p column vectors n1, . . . ,np,
and 1 is a p-vector of components 1.

NTMMTNt = NTMR+ λ− µ1
λiti = 0 , i = 1, . . . , p∑p
i=1 ti = 1 .
(7)
II. Statistical sampling approach A statistical sampling method can also find the optimal
vector t0 ∈ D that minimizes the total deviation f(t).
10
Step (a). Set an initial threshold δ =
∑p
i=1 b
2
i (t
∗), i.e. the total deviation with initial value
t
∗ = (1/p, . . . , 1/p).
Step (b). Take a random sample (t1, . . . , tp−1) from uniform distribution Unif [0,1] and take the
sum.
Step (c). If (t1+ . . .+ tp−1) ≤ 1 set tp = 1− (t1+ . . .+ tp−1) and go to Step (d). Otherwise, discard
the sample and repeat Steps (b) and (c) until the condition (t1 + . . .+ tp−1) ≤ 1 is satisfied.
Step (d). Check the total deviation f(t) in equation (5). If f(t) < δ, update the threshold by
setting δ = f(t). If not, repeat the above steps with a new sample.
Step (e). Repeat the above steps (b-d) to achieve a reasonably small total deviation δ.
Step (f). Repeat Step (e) to fine-tune the search by shrinking the sampling domain from [0,1] to a
small one [ti − δi1, ti + δi2] for ti (i = 1, . . . , p− 1) with δi2 − δi1 → 0 and ti − δi1 ≥ 0, ti + δi1 ≤ 1.
This fine-tuning leads to the convergence of t by the existence and uniqueness in Theorems 1 and
2.
Comparison of cancer mortality rates by age - standardization methods The crude rate
was set as the reference for comparison, the cumulative rate and the age-adjusted rates using the
US Year 2000 Population Standard and the mean reference population were compared to the crude
rate. The relative deviation was calculated and reported as a percentage for each population i, and
the mean deviation of an age adjusted rate was calculated with equation (8) below as an average
over all p populations and used to assess an age adjustment method.√∑p
i=1(m
T
i n−m
T
i ni)
2
p
(8)
A large mean deviation indicates inaccurate estimation while a small one indicates accurate esti-
mation.
Software SEER*Stat Version 7.1.0 [29] was used to generate the total US population-based cancer
mortality rates. CanQues Version 4.2 [30] was used to calculate disease prevalence. R version 2.13.0
[34] was used for modeling, data analysis, and producing the figures.
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Table 1: Adjusted Rates Compared to Crude Prostate Cancer Mortality in Six States 1970–2009∗
Year
State Method 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
CA Crude 15.54 17.50 18.98 20.05 21.51 19.44 17.56 17.03
US2000 29.66 31.84 33.47 34.72 36.76 30.84 26.33 23.33
% Dev1 91 82 76 73 71 59 50 37
MeanRef 17.91 19.11 20.11 20.84 21.82 18.12 15.25 13.56
% Dev 15 9 6 4 1 -7 -13 -20
Cumul 482.92 499.10 511.47 539.32 551.92 440.27 352.83 308.69
% Dev 3007 2752 2594 2590 2466 2165 1909 1712
MA Crude 19.21 21.25 23.64 25.13 28.80 26.69 23.59 20.78
US2000 31.31 32.68 34.57 36.01 38.87 34.01 28.66 23.17
% Dev 63 54 46 43 35 28 22 12
MeanRef 23.11 24.18 25.38 26.27 28.32 24.43 20.33 16.42
% Dev 20 14 7 5 -2 -8 -14 -21
Cumul 499.05 527.05 529.31 528.14 567.52 473.18 359.01 275.71
% Dev 2498 2381 2139 2002 1871 1673 1422 1227
MI Crude 16.63 18.51 20.82 23.84 27.26 25.14 21.44 18.85
US2000 31.68 33.91 34.99 37.33 40.91 36.09 28.71 22.45
% Dev 90 83 68 57 50 44 34 19
MeanRef 21.06 22.27 22.90 24.38 26.15 22.64 17.88 14.04
% Dev 27 20 10 2 -4 -10 -17 -25
Cumul 539.70 549.20 569.68 585.61 616.35 501.73 384.85 289.05
% Dev 3145 2868 2637 2357 2161 1896 1695 1434
MO Crude 20.93 22.87 23.38 26.21 28.96 26.11 21.01 19.99
US2000 29.37 31.78 31.18 33.84 36.61 32.94 26.10 23.09
% Dev 40 39 33 29 26 26 24 15
MeanRef 23.30 24.85 24.30 26.39 28.38 25.05 19.51 17.49
% Dev 11 9 4 1 -2 -4 -7 -13
Cumul 495.14 502.12 481.57 524.52 540.68 459.26 325.60 308.95
% Dev 2265 2095 1959 1901 1767 1659 1449 1445
NJ Crude 17.53 20.38 23.09 25.70 29.68 26.98 22.43 19.08
US2000 31.36 33.42 35.48 36.95 40.80 35.19 28.13 22.30
% Deviate 79 64 54 44 37 30 25 17
MeanRef 22.28 23.75 24.91 26.11 28.46 24.37 19.19 15.28
% Dev 27 17 8 2 -4 -10 -14 -20
Cumul 524.23 542.64 546.12 574.13 604.50 510.12 373.19 302.53
% Dev 2891 2563 2265 2134 1937 1791 1563 1485
NY Crude 18.15 20.57 22.94 24.58 27.23 24.83 22.12 19.30
US2000 28.61 31.12 33.13 34.42 37.80 33.27 28.02 22.49
% Dev 58 51 44 40 39 34 27 16
MeanRef 21.22 22.74 24.02 25.16 27.13 23.66 19.71 15.83
% Dev 17 11 5 2 0 -5 -11 -18
Cumul 486.59 504.17 529.21 548.42 572.84 489.36 386.83 310.59
% Dev 2581 2351 2207 2131 2003 1871 1649 1509
∗ Unit of mortality rate is per 105 person-year.
1 Percentage of deviation from the crude rate.
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Table 2: Expected Number of Deaths by Summary Rates Compared to Observed Number of Deaths
Year
State Method 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
CA Obs 7760 9503 11457 13657 16276 15530 15000 15169
Crude 7760 9503 11457 13657 16276 15530 15000 15169
US2000 14807 17290 20203 23649 27809 24639 22492 20772
% Dev2 91 82 76 73 71 59 50 37
MeanRef 8940 10380 12136 14192 16509 14474 13030 12075
% Dev 15 9 6 4 1 -7 -13 -20
MA Obs 2600 2872 3215 3521 4119 3945 3597 3199
Crude 2600 2872 3215 3521 4119 3945 3597 3199
US2000 4238 4417 4701 5046 5561 5028 4370 3567
% Dev 63 54 46 43 35 28 22 12
MeanRef 3129 3268 3452 3682 4050 3611 3100 2528
% Dev 20 14 7 5 -2 -9 -14 -21
MI Obs 3610 4078 4553 5223 6180 5938 5194 4561
Crude 3610 4078 4553 5223 6180 5938 5194 4561
US2000 6876 7473 7654 8181 9274 8525 6956 5433
% Dev 90 83 68 57 50 44 34 19
MeanRef 4570 4908 5009 5341 5927 5347 4332 3398
% Dev 27 20 10 2 -4 -10 -17 -25
MO Obs 2357 2627 2732 3135 3595 3418 2865 2835
Crude 2357 2627 2732 3135 3595 3418 2865 2835
US2000 3307 3650 3643 4047 4544 4311 3558 3273
% Dev 40 39 33 29 26 26 24 15
MeanRef 2623 2854 2839 3156 3523 3280 2661 2481
% Dev 11 9 4 1 -2 -4 -7 -13
NJ Obs 3042 3553 4068 4674 5570 5298 4589 3983
Crude 3042 3553 4068 4674 5570 5298 4589 3983
US2000 5442 5826 6251 6721 7657 6912 5754 4655
% Dev 79 64 54 44 37 30 25 17
MeanRef 3867 4141 4388 4750 5342 4786 3926 3190
% Dev 27 17 8 2 -4 -10 -14 -20
NY Obs 7791 8616 9476 10343 11739 11016 10061 8832
Crude 7791 8616 9476 10343 11739 11016 10061 8832
US2000 12282 13036 13688 14482 16296 14761 12746 10288
% Dev 58 51 44 40 39 34 27 16
MeanRef 9111 9526 9922 10584 11694 10497 8963 7243
% Dev 17 11 5 2 0 -5 -11 -18
2 Percentage of deviation from the observed number.
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Table 3: Comparison of Age-adjusted Case Fatality Rate to Crude Rate in US in 2008∗
Mean Cancer Site
Rate Deviationb Breast Cervix Prostate Lung Leukemia Colon-Rect
Crude 0 1380.6 1170.5 1088.3 19771.7 3705.3 3201.5
US2000 4305.1 941.7 683.9 243.4 9384.5 2265.3 2900.3
% Deva -31.79 -41.57 -77.63 -52.54 -38.86 -9.41
MeanRef 403.4 1394.1 1295.7 845.2 19344.1 4538.4 3358.1
% Deva 0.98 10.70 -22.34 -2.16 22.48 4.89
Cumul 53351.3 10867.8 9789.3 4175.9 145146.2 28241.8 27358.2
% Dev 687.19 736.36 283.71 634.11 662.19 754.55
∗ Unit of case fatality rate is per 105 person-year.
a Negative deviation indicates underestimation.
b Mean deviation is calculated as the square-root of the average of the squared
deviation over all six cancer sites, see equation (8) in Methods.
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SUPPLEMENTARY MATERIALS
Data
Generating Cancer Mortality and Case Fatality Rates
We generate prostate cancer mortality rate of each state with the US SEER 9 registration data using
the Mortality All COD - Aggregated with State, Total US (1969-2009) <Katrina/Rita Population
Adjustment> with the state specified to be one of the six states and gender specified to be “Male”
and Site and Morphology Cause of Death Record to be “Prostate”. Eight 5 year periods (1970–74,
. . ., 2005–09) were specified to generate the age–specific cancer mortality rate for the eight periods.
By default, the numbers of cases less than 10 were set to 0 with a corresponding mortality rate 0.
The newborn group age 0 was excluded for data analysis and the remaining 18 age groups (1–4,
5–9, . . ., 80-84, and 85+) were used for data analysis.
We generate the cancer mortality rate with the US SEER 9 registry data using the incidence-
based mortality (IBM) database (31), the Incidence-Based Mortality - SEER 9 Regs Research Data,
Nov 2011 Sub Vintage 2009 Pops (1973-2009) <Katrina/Rita Population Adjustment>. Following
the IBM instruction (31), we specify the maximum number of months of the “Survival time recode”
in the database to ensure that all cancer records in the database are included in calculating the
age-specific mortality rate for the year 2008. Also generated by the SEER*Stat software are the
numbers of deaths reported in 2008 by age group and the numbers of people in the general public
(including healthy people). Similar to the above, we exclude the age 0 group and thus have the
mortality rates, the numbers of deaths, and the population exposures in 18 age groups (age 1-4,
5-9, . . . , 80 and 85+). Note that although SEER*Stat is used to estimate mortality rate based on
the total population in the database, it does not provide patient exposure-based case fatality rate
(25). We further generate the prevalence of each cancer as of January 1, 2009 by the same 18 age
groups using CanQues, and calculate the case fatality rate as follows.
Letmp denote the mortality rate based on the general population (including the healthy people),
mc the case fatality rate based on the cancer patient exposure to death from the disease, D the
number of deaths from the disease, E the cancer patient exposure, Pop the total population, and
Prev the prevalence of the disease in the general population. It can be seen that
mc =
D
E
=
D
Pop× Prev
=
mp
Prev
, [9]
i.e., each age-specific case fatality rate mc can be calculated with the age-specific mortality rate mp
divided by the age-specific prevalence of the disease Prev. Note that the following two rules apply
in calculating the mortality rates:
1) If the age-specific prevalence Prev = 0, the mortality rate mc is set to be 0.
2) To ensure the stability of mortality rate based on a small number of cases, the age-specific case
fatality rate mc is set to be 0 if the age-specific number of deaths is small (D < 5).
Table S1 displays the person-year exposure in 2008 by cancer site and age group and the US
Year 2000 Population Standard by age group. Table S2 displays the case fatality rates in 2008 by
age group of six cancer sites: female breast, cervix, prostate, lung, leukemia, and colon-rectum.
Tables S3–S14 in the Supplementary Materials display the mortality rate and population exposure
during 1970–2009 of the six states. The newborn group of age 0 is excluded from all tables as they
are not considered for cancer mortality in this study.
1
Table S1. Distribution of US Cancer Patient of Six Sites and US Year 2000 Population Standard1
Age Cancer Site US 2000
(year) Female Breast Cervix Prostate Lung Leukemia Colon-Rectum (×1000)
1-4 0.0 0.0 0.0 0.0 288.4 0.0 15191.6
5-9 0.0 0.0 0.0 0.0 798.1 0.0 19919.8
10-14 2.0 2.9 0.0 2.1 963.7 0.0 20056.8
15-19 6.0 3.0 0.0 9.3 1169.0 0.0 19819.5
20-24 30.3 37.9 0.0 23.5 1016.5 51.0 18257.2
25-29 209.5 147.2 0.0 54.5 1015.0 167.8 17722.0
30-34 825.1 457.9 0.0 78.0 898.8 335.3 19511.4
35-39 2665.1 1110.3 18.6 152.1 893.8 696.6 22180.0
40-44 6535.6 1681.6 279.9 345.9 802.9 1574.9 22479.2
45-49 13663.2 2315.5 1534.3 916.9 1071.2 2900.7 19805.8
50-54 21312.3 2683.2 5756.7 1926.7 1332.3 5505.3 17224.4
55-59 27213.8 2763.8 13937.6 2840.2 1699.5 7808.3 13307.2
60-64 31922.1 2274.7 25540.1 4160.4 2044.7 9616.8 10654.2
65-69 30378.7 1690.6 33205.4 5175.3 2079.9 10896.1 9409.9
70-74 26981.9 1256.4 36867.2 5293.5 2028.9 12527.7 8725.6
75-79 25525.1 961.1 38201.6 5244.7 2009.4 14127.7 7414.6
80-84 23685.1 617.2 33037.0 4189.4 1815.1 14773.0 4900.2
85+ 25249.0 536.8 26454.0 2766.4 1687.5 18098.4 4259.2
1Fraction person-year exposure is due to the conversion from total population by disease prevalence.
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Table S2. US Age-specific Case Fatality Rate (10−5 person-year) of six Cancer Sites in 2008
Age Cancer Site
(year) Female Breast Cervix Prostate Lung Leukemia Colon-Rectum
1-4 0.0 0.0 0.0 0.0 2424.6 0.0
5-9 0.0 0.0 0.0 0.0 876.5 0.0
10-14 0.0 0.0 0.0 0.0 623.0 0.0
15-19 0.0 0.0 0.0 0.0 599.3 0.0
20-24 0.0 0.0 0.0 0.0 1474.9 0.0
25-29 0.0 0.0 0.0 0.0 1380.2 7750.0
30-34 1575.9 1092.6 0.0 10250.0 1780.9 4470.9
35-39 2363.8 1260.8 0.0 10527.0 1119.5 6174.0
40-44 1713.7 832.8 0.0 11857.1 2615.4 4508.5
45-49 1690.6 906.8 456.5 18213.3 2148.1 4171.5
50-54 1398.2 1304.4 330.1 18322.3 2552.3 3306.0
55-59 1355.9 1085.5 466.4 19470.5 3294.6 3393.8
60-64 1181.0 967.3 536.4 19132.5 3618.8 3098.7
65-69 1168.6 1656.3 605.3 17796.1 3269.5 3184.6
70-74 1145.2 955.0 783.9 19552.3 5766.6 2785.8
75-79 1214.5 2081.2 997.3 20802.1 4976.5 2909.2
80-84 1397.5 1458.2 1440.8 21292.0 7823.0 2931.0
85+ 1952.6 1303.7 2884.2 24833.7 9362.8 3447.8
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Table S3. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in California
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.22 0.20 0.00 0.30 0.18
45-49 0.67 0.79 0.78 0.89 0.71 0.80 0.75 0.54
50-54 3.61 3.73 4.48 3.99 3.57 3.10 2.95 2.69
55-59 11.07 12.39 13.31 12.60 13.12 10.99 8.11 8.68
60-64 30.86 31.37 35.91 36.06 35.76 28.59 23.70 21.08
65-69 64.99 69.14 74.57 76.33 77.50 62.18 46.59 43.93
70-74 134.76 142.94 138.91 151.10 150.68 123.16 91.81 79.66
75-79 236.94 238.73 243.51 258.12 270.40 211.45 178.62 151.92
80-84 362.30 388.02 413.94 425.28 444.56 355.77 315.44 280.77
85+ 507.62 580.92 625.84 639.94 726.02 672.19 607.72 541.34
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Table S4. Population Proportions during 1970 – 2009 in California
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.066 0.058 0.063 0.066 0.073 0.069 0.060 0.058
5-9 0.092 0.079 0.071 0.075 0.079 0.085 0.078 0.070
10-14 0.101 0.089 0.077 0.068 0.073 0.077 0.081 0.077
15-19 0.099 0.099 0.087 0.079 0.070 0.073 0.077 0.081
20-24 0.096 0.103 0.105 0.097 0.085 0.072 0.078 0.078
25-29 0.082 0.095 0.105 0.106 0.096 0.085 0.076 0.077
30-34 0.067 0.080 0.093 0.099 0.099 0.090 0.081 0.072
35-39 0.058 0.062 0.073 0.084 0.088 0.089 0.082 0.075
40-44 0.059 0.055 0.057 0.066 0.074 0.078 0.081 0.076
45-49 0.060 0.054 0.049 0.051 0.058 0.066 0.072 0.075
50-54 0.056 0.054 0.047 0.043 0.045 0.053 0.061 0.067
55-59 0.047 0.049 0.047 0.040 0.037 0.039 0.047 0.056
60-64 0.038 0.040 0.041 0.038 0.033 0.032 0.035 0.042
65-69 0.030 0.032 0.033 0.033 0.031 0.029 0.028 0.030
70-74 0.021 0.023 0.024 0.024 0.025 0.025 0.024 0.023
75-79 0.014 0.015 0.016 0.016 0.017 0.019 0.019 0.019
80-84 0.008 0.008 0.009 0.009 0.010 0.011 0.013 0.013
85+ 0.005 0.005 0.006 0.006 0.006 0.007 0.008 0.010
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Table S5. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in Massachusetts
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
45-49 0.00 0.00 1.68 0.00 0.00 0.00 0.00 1.20
50-54 4.31 4.72 3.46 3.64 4.12 3.69 3.17 3.34
55-59 9.80 9.48 12.45 11.42 13.51 11.57 8.68 6.38
60-64 26.45 27.16 33.75 35.30 37.39 22.79 22.52 16.54
65-69 68.11 74.38 73.67 70.23 76.88 57.33 48.72 39.35
70-74 135.62 144.99 142.55 154.44 164.39 131.34 91.42 72.20
75-79 254.76 266.32 261.75 253.10 271.25 246.46 184.51 136.69
80-84 419.33 437.60 405.24 433.59 444.32 432.50 333.59 289.91
85+ 522.41 532.91 676.40 740.08 829.64 732.48 726.27 586.71
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Table S6. Population Proportions during 1970 – 2009 in Massachusetts
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.067 0.054 0.052 0.057 0.061 0.057 0.052 0.049
5-9 0.095 0.080 0.065 0.065 0.071 0.076 0.069 0.064
10-14 0.106 0.096 0.081 0.065 0.065 0.070 0.074 0.069
15-19 0.100 0.104 0.095 0.082 0.065 0.066 0.072 0.077
20-24 0.087 0.096 0.103 0.096 0.085 0.066 0.068 0.073
25-29 0.074 0.086 0.095 0.102 0.093 0.082 0.068 0.068
30-34 0.059 0.073 0.084 0.091 0.094 0.087 0.076 0.064
35-39 0.053 0.057 0.069 0.081 0.086 0.089 0.083 0.072
40-44 0.057 0.051 0.054 0.067 0.076 0.081 0.085 0.079
45-49 0.059 0.054 0.048 0.052 0.062 0.072 0.077 0.081
50-54 0.058 0.056 0.051 0.045 0.048 0.059 0.068 0.074
55-59 0.051 0.053 0.052 0.046 0.041 0.044 0.054 0.064
60-64 0.043 0.045 0.047 0.045 0.041 0.037 0.040 0.049
65-60 0.033 0.036 0.038 0.039 0.038 0.035 0.032 0.035
70-74 0.025 0.026 0.028 0.029 0.031 0.031 0.029 0.027
75-79 0.017 0.017 0.018 0.020 0.022 0.024 0.024 0.023
80-84 0.010 0.011 0.011 0.011 0.013 0.015 0.016 0.017
85+ 0.006 0.007 0.008 0.008 0.008 0.009 0.011 0.013
7
Table S7. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in Michigan
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
45-49 1.26 1.11 1.34 1.04 0.00 1.11 1.00 0.73
50-54 3.74 2.73 3.55 4.47 3.82 2.76 3.13 3.46
55-59 14.04 14.17 13.14 15.85 12.43 11.77 9.82 8.56
60-64 31.78 34.80 36.82 38.11 38.41 29.30 21.38 20.18
65-69 79.88 81.33 81.75 82.80 84.97 66.60 50.59 40.86
70-74 155.20 158.34 158.39 165.75 168.89 135.68 102.56 81.66
75-79 253.81 256.72 274.69 277.57 307.82 254.50 196.35 133.60
80-84 398.95 425.01 419.97 474.40 498.26 432.96 338.74 252.75
85+ 474.85 569.07 605.01 654.68 808.06 802.12 670.45 551.83
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Table S8. Population Proportions during 1970 – 2009 in Michigan
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.074 0.064 0.063 0.063 0.065 0.060 0.056 0.053
5-9 0.102 0.090 0.079 0.080 0.079 0.081 0.075 0.070
10-14 0.114 0.101 0.090 0.077 0.078 0.078 0.081 0.076
15-19 0.106 0.107 0.096 0.086 0.076 0.077 0.077 0.080
20-24 0.084 0.095 0.097 0.086 0.077 0.068 0.071 0.071
25-29 0.074 0.086 0.092 0.091 0.079 0.072 0.063 0.063
30-34 0.060 0.072 0.082 0.088 0.088 0.079 0.072 0.061
35-39 0.053 0.057 0.067 0.079 0.086 0.086 0.076 0.069
40-44 0.057 0.051 0.054 0.065 0.077 0.082 0.082 0.074
45-49 0.058 0.053 0.048 0.053 0.062 0.072 0.078 0.079
50-54 0.055 0.055 0.050 0.046 0.050 0.058 0.068 0.075
55-59 0.048 0.049 0.050 0.046 0.042 0.045 0.054 0.065
60-64 0.039 0.040 0.043 0.044 0.041 0.037 0.041 0.050
65-69 0.029 0.030 0.034 0.037 0.037 0.034 0.032 0.037
70-74 0.021 0.022 0.024 0.027 0.028 0.029 0.028 0.027
75-79 0.014 0.014 0.016 0.018 0.020 0.021 0.023 0.022
80-84 0.008 0.008 0.009 0.010 0.011 0.012 0.014 0.016
85+ 0.004 0.005 0.006 0.006 0.007 0.008 0.009 0.011
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Table S9. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in Missouri
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
45-49 0.00 0.00 0.00 0.00 1.48 1.33 1.07 0.99
50-54 4.06 4.34 3.75 4.77 4.01 5.21 3.78 2.64
55-59 11.85 10.95 10.40 13.59 15.16 10.65 6.96 8.59
60-64 30.92 29.08 34.20 36.73 34.97 26.99 21.38 22.32
65-69 73.89 74.38 68.84 73.84 74.84 62.27 46.60 41.98
70-74 133.31 131.75 130.50 135.31 151.68 130.53 87.08 83.02
75-79 241.11 251.63 233.88 260.29 258.53 222.28 158.73 149.41
80-84 341.65 393.60 373.19 402.01 463.89 382.68 316.66 272.11
85+ 487.69 571.25 593.84 642.35 709.94 734.11 642.25 534.02
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Table S10. Population Proportions during 1970 – 2009 in Missouri
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.067 0.061 0.064 0.064 0.062 0.058 0.056 0.055
5-9 0.094 0.082 0.075 0.079 0.078 0.078 0.072 0.069
10-14 0.107 0.094 0.082 0.075 0.079 0.079 0.078 0.073
15-19 0.101 0.104 0.092 0.080 0.074 0.078 0.078 0.077
20-24 0.082 0.091 0.095 0.083 0.073 0.068 0.072 0.073
25-29 0.070 0.081 0.088 0.090 0.078 0.070 0.064 0.068
30-34 0.059 0.068 0.078 0.085 0.088 0.077 0.069 0.063
35-39 0.053 0.056 0.064 0.075 0.082 0.085 0.075 0.067
40-44 0.055 0.052 0.055 0.063 0.073 0.079 0.082 0.072
45-49 0.057 0.053 0.050 0.053 0.060 0.069 0.075 0.078
50-54 0.055 0.054 0.050 0.047 0.050 0.057 0.066 0.072
55-59 0.050 0.050 0.050 0.047 0.044 0.047 0.054 0.062
60-64 0.046 0.045 0.045 0.046 0.043 0.040 0.043 0.050
65-69 0.039 0.039 0.039 0.039 0.040 0.037 0.035 0.038
70-74 0.028 0.030 0.031 0.031 0.031 0.032 0.030 0.030
75-79 0.019 0.020 0.022 0.023 0.023 0.023 0.024 0.023
80-84 0.012 0.012 0.012 0.013 0.014 0.014 0.015 0.016
85+ 0.007 0.007 0.008 0.009 0.009 0.010 0.010 0.011
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Table S11. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in New Jersey
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
45-49 1.24 0.00 1.72 0.00 1.07 0.71 1.01 1.39
50-54 4.12 4.74 4.74 4.99 3.38 4.22 2.99 2.49
55-59 11.51 10.19 12.28 15.85 14.74 11.77 8.64 8.08
60-64 34.03 33.37 35.28 37.12 39.01 33.92 23.68 22.07
65-69 66.53 81.69 75.08 83.62 86.97 71.40 54.16 41.72
70-74 143.24 146.82 145.70 164.11 166.76 139.84 101.66 80.57
75-79 263.56 265.84 271.33 268.44 292.58 248.27 181.05 146.20
80-84 363.80 431.40 427.61 447.25 502.60 402.65 334.34 238.08
85+ 532.54 550.08 673.93 684.08 810.78 756.29 658.09 535.58
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Table S12. Population Proportions during 1970 – 2009 in New Jersey
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.067 0.056 0.054 0.057 0.063 0.060 0.056 0.054
5-9 0.096 0.082 0.069 0.068 0.071 0.077 0.074 0.069
10-14 0.106 0.097 0.083 0.069 0.068 0.071 0.077 0.074
15-19 0.095 0.100 0.094 0.080 0.068 0.067 0.069 0.074
20-24 0.075 0.083 0.088 0.086 0.072 0.062 0.062 0.064
25-29 0.069 0.078 0.084 0.089 0.084 0.071 0.065 0.065
30-34 0.060 0.071 0.080 0.088 0.094 0.087 0.075 0.066
35-39 0.057 0.060 0.072 0.081 0.087 0.092 0.084 0.074
40-44 0.062 0.056 0.060 0.070 0.077 0.082 0.087 0.081
45-49 0.065 0.059 0.053 0.057 0.065 0.072 0.078 0.083
50-54 0.063 0.062 0.056 0.050 0.052 0.060 0.067 0.073
55-59 0.055 0.057 0.056 0.051 0.044 0.046 0.054 0.062
60-64 0.045 0.047 0.050 0.049 0.044 0.039 0.041 0.048
65-69 0.033 0.036 0.039 0.041 0.039 0.036 0.032 0.035
70-74 0.023 0.025 0.028 0.030 0.032 0.031 0.029 0.027
75-79 0.015 0.016 0.018 0.020 0.022 0.023 0.023 0.022
80-84 0.009 0.009 0.010 0.011 0.012 0.014 0.015 0.016
85+ 0.005 0.006 0.006 0.007 0.007 0.009 0.010 0.012
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Table S13. Prostate Cancer Mortality Rate (10−5) during 1970 – 2009 in New York
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5-9 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
15-19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
20-24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
25-29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
30-34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
35-39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
40-44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
45-49 1.56 0.85 1.18 1.54 1.06 1.10 0.77 0.81
50-54 3.51 4.07 4.54 4.95 3.99 4.43 2.95 2.95
55-59 12.12 11.66 12.80 14.12 12.36 12.18 10.38 8.57
60-64 30.82 31.84 33.03 36.15 36.27 29.65 24.04 19.73
65-69 72.25 72.44 73.20 81.53 85.45 68.30 54.74 44.04
70-74 136.83 137.86 142.83 154.51 158.62 137.89 105.21 83.94
75-79 229.50 245.46 261.62 255.64 275.09 235.81 188.74 150.54
80-84 362.86 394.83 389.17 417.67 443.38 370.03 323.14 253.43
85+ 425.94 518.47 602.90 604.83 750.84 710.66 637.20 515.18
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Table S14. Population Proportions during 1970 – 2009 in New York
Age 1970-74 1975-79 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09
1-4 0.067 0.057 0.057 0.059 0.064 0.061 0.054 0.052
5-9 0.093 0.081 0.070 0.071 0.072 0.078 0.072 0.065
10-14 0.102 0.094 0.082 0.070 0.070 0.073 0.077 0.071
15-19 0.095 0.099 0.093 0.082 0.070 0.072 0.074 0.077
20-24 0.080 0.087 0.092 0.089 0.080 0.069 0.071 0.074
25-29 0.073 0.082 0.087 0.092 0.087 0.077 0.069 0.072
30-34 0.062 0.072 0.082 0.088 0.092 0.085 0.076 0.067
35-39 0.056 0.059 0.069 0.080 0.084 0.087 0.081 0.072
40-44 0.060 0.055 0.058 0.067 0.075 0.079 0.082 0.077
45-49 0.061 0.056 0.051 0.054 0.061 0.070 0.074 0.078
50-54 0.059 0.059 0.054 0.048 0.051 0.058 0.066 0.071
55-59 0.053 0.054 0.054 0.049 0.044 0.045 0.053 0.062
60-64 0.046 0.046 0.048 0.046 0.043 0.039 0.041 0.048
65-69 0.036 0.037 0.038 0.039 0.037 0.035 0.033 0.035
70-74 0.026 0.027 0.028 0.028 0.029 0.030 0.029 0.027
75-79 0.017 0.018 0.019 0.020 0.021 0.022 0.023 0.022
80-84 0.010 0.011 0.011 0.011 0.012 0.013 0.015 0.016
85+ 0.005 0.006 0.007 0.008 0.008 0.009 0.010 0.012
15
Figure S1. Comparison of age-adjusted mortality rates using the US Year 2000 Population
Standard and the mean reference population to the crude rate of prostate cancer in six states
during 1970-2009.
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Figure S2. Age profile of population in California during 1970–2009.
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Figure S3. Age profile of population in Massachusetts during 1970–2009.
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Figure S4. Age profile of population in Michigan during 1970–2009.
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Figure S5. Age profile of population in Missouri during 1970–2009.
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Figure S6. Age profile of population in New Jersey during 1970–2009.
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Figure S7. Age profile of population in New York during 1970–2009.
22
